Psychiatry Drug Alerts

Psychiatry Drug Alerts is an 8-page monthly update on the efficacy and safety of psychiatric drugs. The ALERTS in Psychiatry Drug Alerts are summaries, from a variety of journals, that can help you solve a problem, warn you about safety, or reassure you about efficacy. You can be assured that Psychiatry Drug Alerts is timely and thorough. We screen over 20,000 citations per week. You can also be assured of objectivity because Psychiatry Drug Alerts is independent. There is no sponsorship or advertisers of any kind associated with Psychiatry Drug Alerts. In fact we call special attention to manufacturer-sponsored studies.

You'll find well-written, easy to read updates from a diverse selection of journals. Here's a selection from recent issues. . .

Managing NMS Current Treatment	Options in Neurology
Fish Oil Supplementation in Pregnancy	Archives of Disease in Childhood
Sibutramine for Clozapine Weight Gain	Acta Psychiatrica Scandinavica
SSRIs and Fracture Risk	Archives of Internal Medicine
Lamotrigine in Older Patients	Int’l J of Geriatric Psychiatry
Moclobemide SSRI Comparison	Canadian J of Psychiatry
Ramelteon in Sleep Apnea	Sleep and Breathing

View Sample Issue	Subscribe
CME Program	Log In

Drug Alerts are monthly newsletters about the efficacy and safety of drugs and therapeutics that will: Alert you to drug safety concerns; Help you solve difficult treatment problems; Save you time.

The goal of our newsletters is to provide a summary of clinically important research findings to health care professionals. Click on your specialty above or choose a newsletter in the publications menu for more specific information and to view a sample issue.